Raymond James Upgrades Oscar Health to Outperform – Sees Big Upside
Raymond James upgrades Oscar Health stock to Outperform with $18 target, calling valuations attractive as margins improve in ACA market and forward outlook strengthens.
/ 10 items
#OSCR↓
Oscar Health Q4 Results: Loss Widens but Growth and Profitability Plans Remain
Oscar Health reports wider quarterly losses due to higher medical costs, while revenue grows and the company targets profitability in 2026.
Trump Administration Proposes Near-Flat Medicare Advantage Rates, Disappointing Insurers
Trump's CMS proposes minimal 0.09% Medicare payment increase for 2027, far below Wall Street's 4-6% expectations, while eliminating controversial billing practices.
Barclays Upgrades Oscar Health as Managed Care Outlook Improves
Barclays upgraded Oscar Health to Equal Weight, raising its price target to $18 as analysts see margin expansion and renewed interest in managed care stocks in 2026.
Senate Fails to Save Obamacare Subsidies; Premiums Will Soar
Over 20 million Americans face sharply higher health insurance costs after the Senate rejected both Republican and Democratic plans to extend expiring Affordable Care Act tax credits.
Piper Sandler Upgrades Oscar Health to Overweight, Sees Strong Profit Potential
Piper Sandler upgrades Oscar Health to Overweight with a $25 price target, citing growth and profitability potential through 2027.